Movement Disorders - Short communication

Journal of Neural Transmission

, Volume 119, Issue 4, pp 455-456

First online:

CSF biomarkers in different phenotypes of Parkinson disease

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


CSF biomarker studies were performed in 6 patients each with tremor-dominant (TD) and non-tremor-dominant (NT) Parkinson disease (PD) patients, 27 Alzheimer disease (AD) and 17 age-matched controls. In both NT-PD and AD patients total tau levels and the cortex tau/Aβ-42 were significantly increased compared to both TD-PD patients and controls (p < 0.01). These data in a small cohort confirm previous studies, corroborating the opinion that CSF levels of tau protein and the index total-tau/Aβ-42 may be potential markers of the severity of neurodegeneration in PD.


Parkinson disease Clinical phenotypes CSF biomarkers Total-tau/Aβ-42